3-Phenyl-hexadien-(2cis.4trans)-saeure-ethylester | 19367-44-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 3-Phenyl-hexadien-(2cis.4trans)-saeure-ethylester
• 英文别名: ethyl (2E,4E)-3-phenylhexa-2,4-dienoate
• CAS: 19367-44-3
• 化学式: C₁₄H₁₆O₂
• 分子量: 216.28
• InChiKey: ZAENTEBYSYGZGY-QOIIATOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• USE OF PENTADIENOIC ACID DERIVATES FOR TREATEMENT OF HYPERURICEMIA
  申请人：Merck Patent GmbH

  公开号：EP1686983B1

  公开（公告）日：2007-07-11
• Use of pentadienoic acid derivatives for the treatment of hyperuricemia
  申请人：Boizel Robert

  公开号：US20070099854A1

  公开（公告）日：2007-05-03

  The use of a pentadienoic acid derivative of formula (I) for the preparation of a medicament for the prevention or treatment of hyperuricemia and/or one or several associated disorders or diseases, and/or for reducing the serum uric acid level of a subject. Medical compositions for these prevention and/or treatment, comprising such a pentadienoic acid derivative.
• USE OF PENTADIENOIC ACID DERIVATIVES FOR THE TREATMENT OF HYPERURICEMIA
  申请人：Boizel Robert

  公开号：US20100160410A1

  公开（公告）日：2010-06-24

  The use of a pentadienoic acid derivative of formula (I) for the preparation of a medicament for the prevention or treatment of hyperuricemia and/or one or several associated disorders or diseases, and/or for reducing the serum uric acid level of a subject. Medical compositions for these prevention and/or treatment, comprising such a pentadienoic acid derivative.